The Impact of Label Changes (Boxed Warning) on Real-World Febuxostat Utilization in Patients with Gout: A Cross-Sectional Drug Utilization Study

INTRODUCTION: This drug utilization study evaluated the impact of 2019 label changes on real-world febuxostat utilization among patients with gout. We describe the numbers and proportions of patients initiating febuxostat as new users (allopurinol-naïve) or prevalent new users (prior allopurinol use...

Descripción completa

Detalles Bibliográficos
Autores principales: Sosinsky, Alexandra Z., Song, Yufei, Gunawardhana, Lhanoo, Phillips, Syd, Page, Matt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469119/
https://www.ncbi.nlm.nih.gov/pubmed/37460856
http://dx.doi.org/10.1007/s40744-023-00581-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469119/
https://www.ncbi.nlm.nih.gov/pubmed/37460856
http://dx.doi.org/10.1007/s40744-023-00581-x

Ejemplares similares